(Q47788413)

English

Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients

scientific article published in May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

Tangier disease

1 reference

based on heuristic

inferred from title

author name string

von Eckardstein A

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

Huang Y

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

Kastelein JJ

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

Geisel J

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

Real JT

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

Kuivenhoven JA

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

Miccoli R

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

Noseda G

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

Assmann G

9

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

138

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

25-34

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Pre-beta HDL: structure and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Regulation of the concentration of pre beta high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Generation of pre-beta 1-HDL and conversion into alpha-HDL. Evidence for disturbed HDL conversion in Tangier disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Biochemical characterization of pre-beta 1 high-density lipoprotein from human ovarian follicular fluid: evidence for the presence of a lipid core

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Severe polyneuropathy in Tangier disease mimicking syringomyelia or leprosy. Clinical, biochemical, electrophysiological, and morphological evaluation, including electron microscopy of nerve, muscle, and skin biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Genetically determined absence of HDL-cholesterol and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Familial high-density-lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descent

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Two novel molecular defects in the LCAT gene are associated with fish eye disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Plasma lipid transfer activities in hyper-high-density lipoprotein cholesterolemic and healthy control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

An investigation of the role of lecithin: cholesterol acyltransferase and triglyceride-rich lipoproteins in the metabolism of pre-beta high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Sodium oleate-facilitated reassembly of apolipoprotein A-I with phosphatidylcholine.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of pre-beta high-density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distri

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Familial HDL deficiency due to marked hypercatabolism of normal apoA-I

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Sex-specific effects of the glutamine/histidine polymorphism in apo A-IV on HDL metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9150(97)00280-3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9678768

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47788413&oldid=2170733553"